IBIO - iBio, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue4443949481,851
Cost of Revenue----
Gross Profit4443949481,851
Operating Expenses
Research Development3,9864,1173,1563,495
Selling General and Administrative10,68510,5517,6855,022
Non Recurring----
Total Operating Expenses14,67114,66810,8418,517
Operating Income or Loss-14,227-14,274-9,893-6,666
Income from Continuing Operations
Total Other Income/Expenses Net-1,881-1,865-76441
Earnings Before Interest and Taxes-14,227-14,274-9,893-6,666
Interest Expense-1,915-1,929-807-807
Income Before Tax-16,108-16,139-10,657-6,625
Income Tax Expense----
Minority Interest-2114,10714,107
Net Income From Continuing Ops-16,108-16,139-10,657-6,625
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-16,105-14,532-9,764-6,625
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-16,365-14,622-9,764-6,625